Literature DB >> 12660865

Z-2 aldose reductase allele and diabetic retinopathy in India.

Govindasamy Kumaramanickavel1, Sarangapani Sripriya, Vedam Lakshmi Ramprasad, Neelam Kumari Upadyay, Pradeep George Paul, Tarun Sharma.   

Abstract

Genetic factors have been identified that regulate the severity and the rapidity of onset of retinopathy in diabetic patients. Polymorphisms in (CA)( n) present upstream of the promoter of the aldose reductase (ALR2 ) gene have been shown to be associated with retinopathy in different ethnic populations. We aimed to study the association between the (CA)( n) polymorphism and type 2 diabetic patients with and without retinopathy in the Asian Indian population. We screened 105 diabetic patients with retinopathy (DR) and 109 diabetic patients without retinopathy (DNR) for the (CA)( n) polymorphism and compared the results with those of an unrelated healthy control group (CT). We identified 13 alleles in our diabetic population. The Z-2 allele (136 bp) showed an association with the DR group (13.81%) with a significant p value (p = 0.029) when compared with the DNR group (7.34%). The Z-2 allele also showed a significant association with those DR patients who had proliferative retinopathy (PDR) and maculopathy (MAC) (p = 0.004). The Z-2 allele is, therefore, a high-risk allele for diabetic retinopathy in the Asian Indian patients.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12660865     DOI: 10.1076/opge.24.1.41.13889

Source DB:  PubMed          Journal:  Ophthalmic Genet        ISSN: 1381-6810            Impact factor:   1.803


  18 in total

Review 1.  The role of genetics in susceptibility to diabetic retinopathy.

Authors:  Gerald Liew; Ronald Klein; Tien Y Wong
Journal:  Int Ophthalmol Clin       Date:  2009

Review 2.  Current state of care for diabetic retinopathy in India.

Authors:  Kim Ramasamy; Rajiv Raman; Manish Tandon
Journal:  Curr Diab Rep       Date:  2013-08       Impact factor: 4.810

3.  MnSOD Val16Ala polymorphism associated with retinopathy risk in diabetes: a PRISMA-compliant Meta-analysis of case-control studies.

Authors:  Lei Huang; Jun Lyu; Qiu-Ping Liu; Cheng Chen; Tong Wang
Journal:  Int J Ophthalmol       Date:  2017-04-18       Impact factor: 1.779

4.  Meta-analysis of the association between aldose reductase gene (CA)n microsatellite variants and risk of diabetic retinopathy.

Authors:  Wensheng Mi; Yan Xia; Yanhui Bian
Journal:  Exp Ther Med       Date:  2019-10-08       Impact factor: 2.447

5.  Genetic and epigenetic modifications in the pathogenesis of diabetic retinopathy: a molecular link to regulate gene expression.

Authors:  Priya Pradhan; Nisha Upadhyay; Archana Tiwari; Lalit P Singh
Journal:  New Front Ophthalmol       Date:  2016-10-24

6.  Absence of diabetic retinopathy in a patient who has had diabetes mellitus for 69 years, and inadequate glycemic control: case presentation: response.

Authors:  Rajiv Raman; Aditi Gupta
Journal:  Diabetol Metab Syndr       Date:  2010-03-25       Impact factor: 3.320

7.  Comparison of three strains of diabetic rats with respect to the rate at which retinopathy and tactile allodynia develop.

Authors:  T S Kern; C M Miller; J Tang; Y Du; S L Ball; L Berti-Matera
Journal:  Mol Vis       Date:  2010-08-15       Impact factor: 2.367

8.  Association analysis of nine candidate gene polymorphisms in Indian patients with type 2 diabetic retinopathy.

Authors:  Suganthalakshmi Balasubbu; Periasamy Sundaresan; Anand Rajendran; Kim Ramasamy; Gowthaman Govindarajan; Namperumalsamy Perumalsamy; J Fielding Hejtmancik
Journal:  BMC Med Genet       Date:  2010-11-10       Impact factor: 2.103

Review 9.  Human genetics of diabetic retinopathy.

Authors:  Z-H Tang; L Wang; F Zeng; K Zhang
Journal:  J Endocrinol Invest       Date:  2014-09-09       Impact factor: 4.256

10.  Novel transgenic mouse models develop retinal changes associated with early diabetic retinopathy similar to those observed in rats with diabetes mellitus.

Authors:  Changmei Guo; Zifeng Zhang; Peng Zhang; Jun Makita; Hiroyoshi Kawada; Karen Blessing; Peter F Kador
Journal:  Exp Eye Res       Date:  2013-12-25       Impact factor: 3.467

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.